EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
Source: EQS
Göttingen, The long-standing CEO of Kreuzburg has been at the helm of the company since 2003. After joining The Chairman of the Supervisory Board of Kreuzburg said: “After so many years at the helm of this special company, I would like to have more space and time for new topics and projects in the future. For the upcoming phase of my life, I am ruling out taking on an executive top role, while I will continue to be involved in my mandates in business and science and will also engage in further business activities, especially in such innovation-driven sectors as biotechnology and medicine. After a phase of extraordinary growth, the entire life science industry is facing temporary challenges in the current "post-pandemic phase", while the prospects for the future remain excellent. The trough has been passed and I will continue to fully focus on Sartorius over the next year and a half and, together with my team, will work with all my energy to ensure that the company continues to develop more innovatively, faster and more profitably than the competition. At the same time, it was important to me to inform the Supervisory Board of my plans at an early point so that they can prepare for my succession without time pressure.” A profile of Sartorius Sartorius (XETRA: SRT3 | STR) is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, based in Göttingen, Visit our newsroom and follow Sartorius on LinkedIn. Contact Head of +49 (0)551.308.1686 petra.kirchhoff@sartorius.com Additional features: File: 240702_Media Release_SAG_Contract CEO_en (1)
|
Language: | English |
Company: | |
Otto-Brenner-Straße 20 | |
37079 Göttingen | |
Phone: | +49.(0)551-308.0 |
Fax: | +49.(0)551-308.3289 |
E-mail: | info@sartorius.com |
Internet: | www.sartorius.com |
ISIN: | DE0007165607, DE0007165631 |
WKN: | 716560 , 716563 |
Indices: | DAX, TecDAX |
Listed: | Regulated Market in |
EQS News ID: | 1937941 |
End of News |
|
1937941 02.07.2024 CET/CEST